Estrogen Metabolites, Oxidative Stress, and the Pathophysiology of Treatment-Resistant Depression

Introduction Major depressive disorder (MDD) is a heterogeneous and disabling illness, affecting more than 300 million individuals worldwide. Despite decades of research and the availability of multiple pharmacological classes—selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, monoamine…

Prehabilitation and Rehabilitation in Radical Cystectomy: Optimizing Health-Related Quality of Life and Functional Outcomes

Radical cystectomy remains the cornerstone treatment for muscle-invasive bladder cancer and selected cases of high-risk non–muscle-invasive disease. Despite refinements in surgical technique, perioperative care, and the use of enhanced recovery pathways, the procedure carries a significant burden of morbidity. Patients…

Erectile Dysfunction, Testosterone, and Cardiovascular Disease: Why Urologists Are the Frontline Guardians of Men’s Health

Introduction Modern medicine often suffers from compartmentalization: cardiologists manage the heart, endocrinologists handle hormones, and urologists concern themselves with the prostate, kidneys, and male sexual function. Yet the biological truth does not respect these professional boundaries. Erectile dysfunction (ED), once…